HARTFORD HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1998-01-01

Employees: 1K

Market Cap: -

Website: https://hhchealth.org

Clinical Trials

THC + CBD and Memory Study

Early Phase 1

Conditions: Cannabis Use
Marijuana Use
Cannabis Intoxication

Interventions: Drug: High THC/No CBD Marihuana
Drug: No THC/No CBD Marihuana
Drug: High THC/High CBD Marihuana

First Posted Date: 2021-04-22

Last Posted Date: 2022-01-06

Lead Sponsor: Hartford Hospital

Target Recruit Count: 9

Registration Number: NCT04855526

Target ADHD Executive Working Memory Study

Not Applicable

Completed

Conditions: ADHD

Interventions: Behavioral: Placebo Training
Behavioral: EWM Training

First Posted Date: 2021-03-12

Last Posted Date: 2023-08-02

Lead Sponsor: Hartford Hospital

Target Recruit Count: 62

Registration Number: NCT04795674

Locations: 🇺🇸
Institute of Living/Hartford Hospital, Hartford, Connecticut, United States

Acute Changes In Thermal Pain Response Following Single Oral Dose of Beta-Cary

Phase 1

Withdrawn

Conditions: Beta-Caryophyllene

Interventions: Drug: Medium Dose Beta-Caryophyllene
Drug: High Dose Beta-Caryophyllene
Drug: Placebo
Drug: Low Dose Beta-Caryophyllene

First Posted Date: 2021-03-11

Last Posted Date: 2021-11-02

Lead Sponsor: Hartford Hospital

Registration Number: NCT04794205

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task

Phase 1

Active, not recruiting

Conditions: CBD

Interventions: Drug: CBD
Drug: Placebo

First Posted Date: 2021-03-03

Last Posted Date: 2024-04-12

Lead Sponsor: Hartford Hospital

Target Recruit Count: 20

Registration Number: NCT04778644

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Inpatient Cognitive-Behavioral Therapy to Reduce Suicide Risk Post-Discharge

Not Applicable

Active, not recruiting

Conditions: Suicide, Attempted

Interventions: Behavioral: Cognitive Behavioral Therapy

First Posted Date: 2019-11-19

Last Posted Date: 2023-07-05

Lead Sponsor: Hartford Hospital

Target Recruit Count: 213

Registration Number: NCT04168645

Locations: 🇺🇸
Institute of Living/Hartford Hospital, Hartford, Connecticut, United States

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

Phase 1

Completed

Conditions: Sepsis

Interventions: Drug: Imipenem-relebactam

First Posted Date: 2019-11-01

Last Posted Date: 2024-08-06

Lead Sponsor: Hartford Hospital

Target Recruit Count: 9

Registration Number: NCT04147221

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Phase 1

Completed

Conditions: Diabetes
Wound Infection
Healthy Volunteers

Interventions: Drug: Omadacycline
Procedure: Microdialysis Catheter Insertion

First Posted Date: 2019-10-30

Last Posted Date: 2021-08-25

Lead Sponsor: Hartford Hospital

Target Recruit Count: 14

Registration Number: NCT04144374

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment

Not Applicable

Completed

Conditions: Pelvic Organ Prolapse
Inflammatory Response
Dysbiosis

Interventions: Other: Standard Care
Other: BiopHreshTM vaginal probiotic supplement (Good Clean Love, Inc. Eugene, OR) and RestoreTM gel.

First Posted Date: 2019-10-07

Last Posted Date: 2022-03-25

Lead Sponsor: Hartford Hospital

Target Recruit Count: 141

Registration Number: NCT04118049

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

What is the Impact of the Presence of a Support Person on Informed Consent

Completed

Conditions: Knowledge, Attitudes, Practice
Prolapse, Vaginal
Urinary Incontinence
Surgery

Interventions: Other: Preoperative support person present
Other: Patient Present Only

First Posted Date: 2019-05-29

Last Posted Date: 2020-04-07

Lead Sponsor: Hartford Hospital

Target Recruit Count: 82

Registration Number: NCT03966469

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs

Phase 4

Completed

Conditions: Pain Management
Post-operative Pain
Total Shoulder Arthroplasty
Osteoarthritis of the Shoulder

Interventions: Drug: Bupivacaine 0.5%
Drug: Liposomal Bupivicaine 1.3%

First Posted Date: 2019-03-25

Last Posted Date: 2023-09-15

Lead Sponsor: Hartford Hospital

Target Recruit Count: 90

Registration Number: NCT03887650

Locations: 🇺🇸
The Bone and Joint Institute at Hartford Hospital, Hartford, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy